No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ORMP240719C2500
- 0.20
- 0.000.00%
15min DelayTrading Jul 17 10:12 ET
0.00High0.00Low
0.00Open0.20Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover1723.04%IV2.66%PremiumJul 19, 2024Expiry Date0.13Intrinsic Value100Multiplier-3DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.5796Delta0.8872Gamma13.15Leverage Ratio-2.4079Theta0.0000Rho7.62Eff Leverage0.0001Vega
Intraday
- 5D
- Daily
News
Oramed Pharmaceuticals (ORMP): Shareholder Letter Spurs Bullish Trend
Express News | Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech
Express News | Oramed Pharmaceuticals And Hefei Tianhui Biotech Finalize Joint Venture; JV To Receive Capital Infusion With HTIT Committing $70M In Cash And Oramed Investing $25M In Cash and Stock
Express News | Oramed Pharmaceuticals: Htit Committing $70 Mln in Cash, Co Investing $25 Mln in Cash & Stock in Jv
Express News | Oramed Pharmaceuticals Inc: Jv With Chinese Partner, Htit
Express News | Oramed Pharmaceuticals Authorizes $20M Buyback
Comments
$Oramed Pharmaceuticals(ORMP.US$ target price $30.00
1
$Oramed Pharmaceuticals(ORMP.US$ Can Not Short Better No Buy DELETE 🤗👊👍
1
Read more